What is the ticker symbol for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals trades under the ticker NBY on AMEX.

What sector does NovaBay Pharmaceuticals operate in?

NovaBay Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NBY in a portfolio?

PortView shows NBY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NovaBay Pharmaceuticals (NBY) Stock Analysis

AMEXHealthcareBiotechnology

$1.47-24.62%

1-year price historyRange $1.01 – $95.80

52-week range$1.47

$1.11$99.75

What NovaBay Pharmaceuticals does

NovaBay Pharmaceuticals, Inc. (NBY) is a pharmaceutical company that specializes in developing and globally distributing products for eyecare and dermatology. Its product portfolio includes Avenova, an advanced solution designed for cleaning the delicate skin around the eye, such as the eyelids, by removing foreign substances, microorganisms, and debris. The company also offers wound management solutions under its NeutroPhase and PhaseOne brands. Furthermore, NovaBay provides a variety of dermatological treatments through its DERMAdoctor brand, addressing diverse skin concerns. These include conditions like keratosis pilaris, rosacea, and eczema, as well as anti-aging formulations, SPF protection, remedies for hyperhidrosis (excessive sweating), solutions for unwanted hair, and acne treatments. The company distributes its products through a multi-channel approach, utilizing traditional retailers, digital beauty platforms, various distributors, and its own online sales channels. Founded in 2000, the company was initially known as NovaCal Pharmaceuticals, Inc., before officially adopting the name NovaBay Pharmaceuticals, Inc. in February 2007. Its corporate headquarters are located in Emeryville, California.

Key metrics

Market cap

$39.14M

P/E (TTM)

-0.05

EPS (TTM)

$-28.50

Beta

0.16

Dividend yield

475.91%

Revenue / share

$0.15

50-day avg

$3.53

200-day avg

$9.62

52-week high

$99.75

52-week low

$1.11

CEO

Michael Kazley

ETFs linked to NBY

Broad-market and Healthcare sector ETFs an investor holding NovaBay Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NBY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NBY in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NovaBay Pharmaceuticals?: NovaBay Pharmaceuticals trades under the ticker NBY on AMEX.
Which exchange is NBY listed on?: NBY is listed on AMEX.
What sector does NovaBay Pharmaceuticals operate in?: NovaBay Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NBY in a portfolio?: PortView shows NBY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.